Alabama Litigation Review

Alabama Litigation Review

Insights & Commentary on Developments in Alabama Litigation

Category Archives: Defective Products

Subscribe to Defective Products RSS Feed

Injury Cases Involving Atrium C-Qur Hernia Mesh Continue To Progress

Posted in Defective Products
At the Blackwell Law Firm website we have a section called Hot Topics. That section provides news and research related to current legal issues. Many of these issues involve injury from bad drugs or dangerous medical devices. Among those topics — two hernia mesh products. These are Ethicon’s Physiomesh and Atrium’s C-Qur mesh. We are currently… Continue Reading

Does The Drug Abilify Cause Compulsive Behaviors?

Posted in Defective Products
It’s difficult to believe. Like many people, I had serious doubts. Very serious doubts. Can a drug really cause compulsive behaviors like uncontrollable gambling? Many Abilify victims suffered the doubts of family and friends. Yet, new medical research now supports a link between the drug and these dangerous compulsive behaviors. WHAT IS ABILIFY? The Food… Continue Reading

New Anticoagulants Continue To Raise Safety Issues

Posted in Defective Products, Personal Injury
In September, I discussed new anticoagulants Xarelto and Eliquis. My prior post concludes by noting patients deserve drugs approved only after careful study for safety. Shortly after that post, the ISMP Quarterwatch also raised issues concerning the safety of new anticoagulants rivaroxaban (Xarelto), dabigatron (Pradaxa), and apixaban (Eliquis). According to Quarterwatch: The adverse event reports for oral… Continue Reading

Invokana And The Risk Of Bone Fractures

Posted in Defective Products
Is Invokana (canagliflozin) a dangerous and defective drug? In a prior post, I discussed the history of Invokana and its link to ketoacidosis. Ketoacidosis can be a life-threatening condition caused by a build-up of acid in the blood. Now, the FDA has issued a new Invokana safety warning. According to the new FDA safety alert:… Continue Reading

First Pradaxa. Then Xarelto. Now Eliquis?

Posted in Defective Products, Personal Injury
Will Eliquis join Pradaxa and Xarelto as another anti-coagulant drug facing claims of severe internal bleeding? Pradaxa was the first of these three new anti-coagulants (blood thinners). It hit the market in 2010. Sales quickly boomed. However, adverse reports of severe internal hemorrhaging and bleeding soon followed. In May 2014, Pradaxa’s manufacturer settled about 4,000… Continue Reading

Invokana – Is The Drug A Safe Treatment For Diabetes?

Posted in Defective Products, Personal Injury
Invokana (canagliflozin) is a relatively new drug marketed to treat Type 2 diabetes. The drug is the first in a new class of medications known as sodium-glucose cotransporter 2 (SGLT2) inhibitors. This class of drugs also includes Farxiga, Glyxambi, Jardiance, and Xigduo XR. How does this new class of drugs work? The drugs work by altering… Continue Reading

Were Clinical Trials For Xarelto Tainted By Misconduct?

Posted in Defective Products, Personal Injury
What is Xarelto? Xarelto (Rivaroxaban) is a relatively new anticoagulant (blood thinner). The FDA first approved Xarelto in 2011. It is distributed in the United States by Johnson & Johnson subsidiary Janssen Pharmaceuticals and Bayer Healthcare. Xarelto was released as a replacement for Coumadin (Warfarin), a blood thinner effectively used for decades. Xarelto is used… Continue Reading

Court Secrecy Harms The Public

Posted in Business Litigation, Defective Products, Personal Injury, Uncategorized
It’s been almost two months since my last post. Although not writing here, I have been busy writing – including a number of briefs in an ongoing products’ liability case and a separate case involving a public contract in Alabama. Both cases share a common (and troubling) issue. Both involve serious public issues shrouded in… Continue Reading

Failed FDA Process Opens Door To Dangerous Medical Devices

Posted in Defective Products, Personal Injury
Power morcellators. Transvaginal mesh. Both are examples of the FDA’s faulty 510(k) process. I’ve written several times about transvaginal mesh – products that have caused tremendous personal injury to women in Alabama and throughout the United States. Last week, I sat through the deposition of our expert witness in one mesh case. This medical specialist… Continue Reading

Boston Scientific Suffers Another Trial Loss Over A Mesh Product

Posted in Defective Products, Federal Courts, Personal Injury
Last week, a Federal Court jury in Florida found Boston Scientific liable for the severe personal injuries caused by one of its transvaginal mesh products. The Florida case involved four women suffering tremendous problems from implanted mesh. The jury assessed $26.7 Million in damages against the company. This was not the first trial loss suffered by… Continue Reading

Update: Injured By A Defective Generic Drug? Where Is The Justice?

Posted in Defective Products
In August, I wrote about the recent Supreme Court decisions shielding generic drug makers from accountability for injuries and deaths caused by their defective drugs. Because generic drug makers were required to use the same warning label as the brand name manufacturer, they were provided immunity for failing to warn of dangerous side effects. This… Continue Reading

Defective Drugs And Research Bias

Posted in Defective Products
We are presently representing clients who have been injured by several different defective medical products, including the diabetes drug Actos and transvaginal mesh. As part of our work, we have studied much of the available medical research. Recently, I viewed an interesting discussion on an issue important in the medical research. The issue is: Why are… Continue Reading

Mesh: Concerns and Questions

Posted in Defective Products
Transvaginal mesh and its complications made headlines this week as a jury reached a $3.35 million compensatory damages verdict in a New Jersey Court, with punitive damages to follow. This bold action ignites concern and questions for thousands of other women implanted with the same device. What is transvaginal mesh? Transvaginal mesh is a medical… Continue Reading

Alabama Will Receive Share of Record Drug Company Fine

Posted in Defective Products, Personal Injury
Drug maker GlaxoSmithKline (Glaxo) will pay a record $3 Billion criminal fraud settlement with the government as a result of its deceptive sales practices. The criminal charges accused Glaxo of practices which pushed dangerous medications on the American public. According to the news, the State of Alabama will receive almost $6 Million of the proceeds.… Continue Reading

Whistleblower Files Suit Against Takeda Over Actos

Posted in Defective Products
Actos litigation is a subject that I have addressed on several occasions. The pending claims continue to move forward. As they progress, we learn more about the manufacturer Takeda’s research and marketing of this diabetes drug to the public. Last week, Bloomberg revealed that a whistleblower has also filed suit against Actos manufacturer Takeda. Add… Continue Reading